These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5552619)

  • 1. The in vivo human myometrial response to withdrawal of estrogen and progestins in the nonpregnant state.
    Moawad AH
    Am J Obstet Gynecol; 1971 Feb; 109(3):359-68. PubMed ID: 5552619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A; Hahn DW; McGuire JL
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation.
    Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1085-1098. PubMed ID: 30325245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites.
    Moursi GE; Abdel-Daim MH; Kelada NL; Abdel-Tawab GA; Girgis LH
    Bull World Health Organ; 1970; 43(5):651-61. PubMed ID: 5313362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of capacitation in the rabbit.
    Hamner CE; Wilson LA
    Fertil Steril; 1972 Mar; 23(3):196-200. PubMed ID: 4110310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of an oral contraceptive progestin-estrogen combination on simian uterine phosphatases.
    Manning JP; Schwartz E; Tornaben JA; Boxill GC; Russell TJ
    Fertil Steril; 1969; 20(5):745-57. PubMed ID: 4980817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of ethynyl estrogens, used with and without progestational agents, on bleeding patterns, weight, and blood pressure.
    Goldzieher JW; Chenault CB; Woutersz TB; Schneider BE; Hansen PR
    Contraception; 1980 Oct; 22(4):369-81. PubMed ID: 7449385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
    Cohen J; Debache C; Solal P; Serkine AM; Achard B; Boujenah A; Pez JP; Paris X; Robert J; Loffredo V
    Hum Reprod; 1987 Jan; 2(1):7-9. PubMed ID: 3106405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.